| Ms Bonnie Betts, OTR/L | |
|
315 129th St S, Tacoma, WA 98444-5044 | |
| (253) 298-3051 | |
| Not Available |
| Full Name | Ms Bonnie Betts |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 315 129th St S, Tacoma, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033469952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 0001831 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Bonnie Betts, OTR/L 315 129th St S, Tacoma, WA 98444-5044 Ph: (253) 298-3051 | Ms Bonnie Betts, OTR/L 315 129th St S, Tacoma, WA 98444-5044 Ph: (253) 298-3051 |
News Archive
Organogenesis, Inc. will have a substantial presence at the 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society being held April 17-20 in Orlando, FL. Results from several clinical and scientific studies will be presented which will further the understanding of Organogenesis' bilayered living cellular construct technology.
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
Two new studies report specific mechanisms of impaired type I interferon (IFN) signaling in some hospitalized patients suffering from severe cases of COVID-19, suggesting that screens for these defects could help identify patients at the highest risk of life-threatening complications from SARS-CoV-2 infection.
SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.
The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1200 HEV-containing blood components (eg, red cells, platelets, and fresh frozen plasma) are likely to be transfused every year in England.
› Verified 4 days ago
Mrs. Katherine Mae Sweigart, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1301 Highlands Parkway North, Tacoma, WA 98406 Phone: 253-752-7112 | |
Jennifer Dawn Colwell, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1818 S Union Ave Ste 1b, Tacoma, WA 98405 Phone: 253-627-7012 | |
Yoseph Kim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5340 N Bristol St, Tacoma, WA 98407 Phone: 253-752-6621 | |
Marianne Hevly Norden, OTR Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 309 S G St Ste 4, Tacoma, WA 98405 Phone: 253-465-3111 Fax: 253-465-3112 | |
Tara Sperry, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10625 Pacific Ave S, Ste B, Tacoma, WA 98444 Phone: 253-302-5074 | |
Mrs. Shauna Lea Irish, MSOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8446 S. 17th Street, Tacoma, WA 98465 Phone: 253-988-3112 | |
Ms. Jami Joanne Savage, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6704 Tacoma Mall Blvd, Tacoma, WA 98409 Phone: 253-475-7466 |